Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
Department of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
PLoS One. 2019 Aug 26;14(8):e0221155. doi: 10.1371/journal.pone.0221155. eCollection 2019.
The criterion for the remission period of chronic cluster headache (CCH) was recently revised from < 1 month to < 3 months in the third edition of the International Classification of Headache Disorders (ICHD-3). However, information on the clinical features of CCH based on the ICHD-3 criteria is currently limited. The present study aimed to investigate the clinical features of CCH based on ICHD-3 using data from the Korean Cluster Headache Registry (KCHR). The KCHR is a multicentre prospective registry of patients with cluster headache (CH) from 15 hospitals. Among the 250 participants with CH, 12 and 176 participants were classified as having CCH and episodic cluster headache (ECH), respectively. Among 12 participants with CCH, 6 (50%) had remission periods of < 1 month, and the remaining 6 (50%) had a remission period of 1-3 months. Six participants had CCH from the time of onset of CH, and in the other 6 participants, CCH evolved from ECH. CCH subjects had later age of onset of CH, developed the condition after a longer interval after CH onset, and had more migraine and less nasal congestion and/or rhinorrhoea than ECH subjects. Clinical features of CCH with remission periods < 1 month were not significantly different from those of CCH with remission periods of 1-3 months, except for the total number of bouts. More current smoking and less diurnal rhythmicity were observed in participants with CCH evolved from ECH compared to those with ECH. In conclusion, the number of subjects with CCH doubled when the revised ICHD-3 criteria were used. Most of clinical characteristics of CCH did not differ when the previous and current version of ICHD was applied and compared. Some clinical features of CCH were different from those of ECH, and smoking may have a role in CH chronification.
慢性丛集性头痛(CCH)缓解期的标准最近在《国际头痛疾病分类(ICHD-3)》第三版中从<1 个月修订为<3 个月。然而,目前基于 ICHD-3 标准的 CCH 临床特征的信息有限。本研究旨在使用来自韩国丛集性头痛登记处(KCHR)的数据,基于 ICHD-3 标准研究 CCH 的临床特征。KCHR 是来自 15 家医院的丛集性头痛(CH)患者的多中心前瞻性登记处。在 250 名 CH 患者中,12 名和 176 名分别被归类为 CCH 和发作性丛集性头痛(ECH)。在 12 名 CCH 患者中,6 名(50%)缓解期<1 个月,其余 6 名(50%)缓解期为 1-3 个月。6 名患者丛集性头痛发病时即患有 CCH,另外 6 名患者由 ECH 发展而来。CCH 患者 CH 的发病年龄较晚,CH 发病后间隔时间较长才发病,且偏头痛的发生率较高,鼻塞和/或流涕的发生率较低。缓解期<1 个月的 CCH 患者的临床特征与缓解期为 1-3 个月的 CCH 患者的临床特征没有显著差异,除了发作次数。与 ECH 患者相比,由 ECH 发展而来的 CCH 患者中,当前吸烟更多,昼夜节律性更差。总之,使用修订后的 ICHD-3 标准时,CCH 的患者数量增加了一倍。当应用和比较 ICHD 的前一版和现行版时,CCH 的大多数临床特征没有差异。CCH 的一些临床特征与 ECH 不同,吸烟可能在 CH 慢性化中起作用。